Gabapentin controlled release - Labopharm
Alternative Names: DDS 2003; Gabapentin sustained release - LabopharmLatest Information Update: 05 Nov 2021
Price :
$50 *
At a glance
- Originator Labopharm
- Class Amines; Aminobutyric acids; Analgesics; Antiepileptic drugs; Antimanics; Antiparkinsonians; Anxiolytics; Cyclohexanecarboxylic acids; Gabapentinoids; Small molecules
- Mechanism of Action CACNA2D1 protein modulators; GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Epilepsy; Neuralgia
Most Recent Events
- 13 May 2004 Preclinical trials in Epilepsy in Canada (unspecified route)
- 13 May 2004 Preclinical trials in Neuralgia in Canada (unspecified route)